Healthy Skepticism Library item: 1238
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Booth B, Zemmel R.
Quest for the best.
Nat Rev Drug Discov 2003 Oct; 2:(10):838-41
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrd/journal/v2/n10/abs/nrd1203_fs.html&dynoptions=doi1114941377
Abstract:
By combining innovative science with years of massive investment, drug makers seek to turn newly discovered chemicals into revolutionary blockbuster drugs that generate billions of dollars in revenue. So every year, they collectively spend tens of billions of dollars on the high-risk pursuit of the next Prozac or Viagra. But should they? This article analyses key themes around differentiation that we have found to be common among blockbusters, and examines the implications for creating future billion-dollar drugs.
Keywords:
Drug Approval*
Drug Costs/trends*
Drug Design*
Drug Evaluation
Drug Industry/economics*
Humans
Safety
Treatment Outcome*
